The difference in acknowledging the AAHRPP between China and America.
- Author:
Ming-jie ZI
1
;
Xu-dong TANG
;
Rui GAO
Author Information
1. Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing.
- Publication Type:Journal Article
- MeSH:
Accreditation;
China;
Clinical Trials as Topic;
legislation & jurisprudence;
Humans;
Public Policy;
United States
- From:
Chinese Journal of Integrated Traditional and Western Medicine
2012;32(8):1117-1120
- CountryChina
- Language:Chinese
-
Abstract:
With the active encouragement of the Chinese government, all domestic clinical research institutes pay more attention to the human research protect program (HRPP) during the process of clinical trials, and actively follow the regulations of medical ethical practice. We could make fully preparation for the accreditation by the correlated international organizations only by further analyzing the Association for Accreditation of Human Research Protection Program (AAHRPP) from a whole and in each accreditation field at different levels, thus having a clear understanding the difference in acknowledging the difference between China's hospitals and America's hospitals.
